Page last updated: 2024-11-06

azumolene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

azumolene: structure given in first source; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

azumolene : A 1,3-oxazole which is substituted by a [(2,4-dioxoimidazolidin-1-yl)imino]methyl group at position 2 and a 4-bromophenyl group at position 5. It is a muscle relaxant used for the treatment/prevention of malignant hyperthermia. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9568620
CHEMBL ID315108
CHEBI ID143225
SCHEMBL ID4071383
MeSH IDM0170257

Synonyms (24)

Synonym
CHEMBL315108
azumolene
64748-79-4
CHEBI:143225
azumolenum
azumoleno
1-({[5-(4-bromophenyl)-1,3-oxazol-2-yl]methylidene}amino)imidazolidine-2,4-dione
1-[[[5-(4-bromophenyl)-2-oxazolyl]methylene]amino]hydantoin
unii-5u7io9cv80
azumoleno [spanish]
azumolene [inn]
2,4-imidazolidinedione, 1-(((5-(4-bromophenyl)-2-oxazolyl)methylene)amino)-
azumolenum [latin]
5u7io9cv80 ,
1-(((5-(p-bromophenyl)-2-oxazolyl)methylene)amino)hydantoin
SCHEMBL4071383
1-[(e)-[5-(4-bromophenyl)-1,3-oxazol-2-yl]methylideneamino]imidazolidine-2,4-dione
1-(((5-(4-bromophenyl)oxazol-2-yl)methylene)amino)imidazolidine-2,4-dione ,
MS-25385
HY-113920A
EX-A4755
BA178067
CS-0143380
AKOS040759535
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID221373Highest tolerated dose (p.o.) in mice.1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
1-[[[5-(substituted phenyl)-2-oxazolyl]methylene]amino]-2,4- imidazolidinediones, a new class of skeletal muscle relaxants.
AID222363Skeletal muscle relaxant activity expressed as Muscle relaxant activity grade at HTD in mice;0=none1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
1-[[[5-(substituted phenyl)-2-oxazolyl]methylene]amino]-2,4- imidazolidinediones, a new class of skeletal muscle relaxants.
AID194777Inhibition of gastrocnemius twitch tension after a cumulative dose of 36.6 mg/kg iv in rats.1987Journal of medicinal chemistry, Feb, Volume: 30, Issue:2
1-[[[5-(substituted phenyl)-2-oxazolyl]methylene]amino]-2,4- imidazolidinediones, a new class of skeletal muscle relaxants.
AID1685005Binding affinity to human CRBN-thalidomide binding domain expressed in Escherichia coli by measuring baseline corrected normalized fluorescence by MST based assay2021ACS medicinal chemistry letters, Jan-14, Volume: 12, Issue:1
Sweet and Blind Spots in E3 Ligase Ligand Space Revealed by a Thermophoresis-Based Assay.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (8.70)18.7374
1990's9 (39.13)18.2507
2000's4 (17.39)29.6817
2010's6 (26.09)24.3611
2020's2 (8.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]